The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations
about
Mutation Profile of Well-Differentiated Thyroid Cancer in AsiansCurrent status and future perspectives in differentiated thyroid cancerSomatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samplesThe changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic reviewAMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCERIntegrated genomic characterization of papillary thyroid carcinomaNomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent TumorsReview of Factors Related to the Thyroid Cancer Epidemic.Update: the status of clinical trials with kinase inhibitors in thyroid cancerNoninvasive Encapsulated Follicular Variant of Papillary Thyroid Cancer: Clinical Lessons from a Community-Based Endocrine Surgical PracticeDiagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis.Clinicopathological features of rare BRAF mutations in Korean thyroid cancer patientsMolecular approaches to thyroid cancer diagnosis.TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomasThe Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades.Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test.Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control studyA loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.No considerable changes in papillary thyroid microcarcinoma characteristics over a 30-year time periodA metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinomaOverexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression.Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinomaAn unexpected finding in the resection specimen of a carcinoma of the oral cavity: A case reportTherapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer.Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma.Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation.Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer.Perspectives of the AMP-activated kinase (AMPK) signalling pathway in thyroid cancer.Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.Modeling anaplastic thyroid carcinoma in the mouse.miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.Effect of Hashimoto thyroiditis on low-dose radioactive-iodine remnant ablation.Encapsulated Thyroid Carcinoma of Follicular Cell Origin.Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.Thyroid nodules and cancer management guidelines: comparisons and controversies.PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells.Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules.
P2860
Q26782322-92C8B92B-2652-4464-B3DF-7CB1DEF40F63Q27024484-6364D5AA-E637-45E3-A96C-099F00A9FCAAQ28070226-882D8019-C005-4532-A907-84B56F04D428Q28076196-F0F8F515-5D96-4B6E-BB03-DA307FC8454CQ28086949-5F5065DE-244A-49B2-986D-3B94545C49F7Q28251986-7906A8D1-A5AA-47D1-9A53-15F16ACF5892Q28274899-6200E48E-09BC-4394-AB3F-72AD60307869Q30234328-1C83EE7F-B524-40F2-BA11-BCED2FAD8095Q33570056-66E6EA90-44A5-43EA-B529-7C7D200465C3Q33608053-A2A220CE-1AC6-41FD-9609-78F4ACB2234FQ33624667-17EA66B0-8EC9-49DE-B7F5-26E2C088B784Q33687689-97C31968-36EC-42C0-A6C5-AA1F8491D71EQ34029917-AB3CBFB8-76CA-4101-978B-48C6AB04020DQ34160828-2E6E92DC-ED10-436B-AED6-9E4CE0BC25DEQ34313648-65C7AD70-1792-49B0-91DA-A69CF2CD1642Q34839781-2BEC2119-B1DC-443A-B4C2-8BCA406E92E3Q35752069-7E0B88B0-1814-4E1B-B078-FC0204B6C0DCQ35893573-11330F27-7006-4AFE-A58D-6125021A037CQ35983871-5EAAD218-D78A-49EC-B8ED-CC7A0702E739Q36003880-631407B0-46E0-42DE-93DA-A08C4A69CFB9Q36151455-DDAE9563-B4EC-4544-BCB0-6A0BA2823204Q36282408-F12A2D14-B117-48A9-82C0-821100158A52Q36328328-99E2E60E-B4AE-4975-806E-9E9B6B3E2C1BQ36586940-2F84C767-FCC7-45B6-86BC-C9F645EE4ADBQ36789492-DC4BF78E-513D-4218-809D-ED6D7EF906CDQ36983658-0B91E09E-E1C4-4170-BA69-427CDCD91BACQ37086254-4B54B1F4-86D0-4C88-B11A-A034A569546EQ37175455-9D8C3C72-DADD-4EB2-8487-F1786915A0AFQ37624102-5513FA3E-D34E-4A1F-B445-FF256018B101Q37702988-2B8B5ABE-4A3D-4574-A9C5-EA55FA52C865Q38243095-1E49927A-D7D9-47E4-AD99-35F3120631DAQ38270915-BF62571D-3C2D-469F-8BBD-D6986FDD9735Q38395979-53F469B9-0E12-42E6-9909-E5ECAF85B8CFQ38426754-7E8160A1-B971-49B4-93E9-4280984ACA56Q38499954-66434B96-E2EA-4229-8EBA-4780039C2F7EQ38614394-01CF944F-90FE-40AB-B0F0-19A88D285396Q38677660-CE4C99C3-9412-4E15-9B54-411F287836B8Q38783191-8C302C5A-B7EB-400E-AED8-59BB41FACB83Q38891514-8B949763-CF29-4938-9542-43CE77806AD4Q39002659-ED427EF9-CDF5-4AA5-A89F-F24825C6A51D
P2860
The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The increase in thyroid cancer ...... harp increase in RAS mutations
@ast
The increase in thyroid cancer ...... harp increase in RAS mutations
@en
The increase in thyroid cancer ...... harp increase in RAS mutations
@nl
type
label
The increase in thyroid cancer ...... harp increase in RAS mutations
@ast
The increase in thyroid cancer ...... harp increase in RAS mutations
@en
The increase in thyroid cancer ...... harp increase in RAS mutations
@nl
prefLabel
The increase in thyroid cancer ...... harp increase in RAS mutations
@ast
The increase in thyroid cancer ...... harp increase in RAS mutations
@en
The increase in thyroid cancer ...... harp increase in RAS mutations
@nl
P2093
P2860
P3181
P356
P1476
The increase in thyroid cancer ...... harp increase in RAS mutations
@en
P2093
Alice J Sigurdson
Alina V Brenner
Jay H Lubin
Samuel A Wells
Yuri E Nikiforov
P2860
P304
P3181
P356
10.1210/JC.2013-2503
P407
P577
2013-11-18T00:00:00Z